The Story Behind the Numbers: What CMI’s Platform Data Says About Contingency Management
Contingency management doesn’t get talked about the way flashier digital health categories do, but its results are hard to argue with. Stimulant use disorder still has no FDA-approved medication — which is a large part of why contingency management is widely considered the strongest evidence-based treatment available for it. What’s less visible from the outside is what that looks like at scale, across real clinics, real clinicians, and real people working toward change.
We pulled together the numbers from our own platform, cumulative as of August 2025, because they tell that story better than any single case study could.
The Headline Result: 96.8% Negative UTOX Results
Of everything in the data, one figure stands out: 96.8% of UTOX results captured on our platform have been negative.
A UTOX, or urine toxicology test, checks a urine sample for the presence of a specific substance — in a contingency management program, that typically means screening for the substance a person is working to stay free of, such as a stimulant like cocaine or methamphetamine. A “negative” result means the substance was not detected — in other words, it confirms the person stayed abstinent during that testing window. That’s the opposite of how “negative” usually reads in a health context: here, negative is the goal, and it’s the outcome the entire model is built to verify and reward.
That distinction is what makes 96.8% such a striking number. It isn’t a satisfaction score or something self-reported — it’s a lab-confirmed rate of abstinence across every test captured on our platform. For a treatment approach built entirely around verifying and reinforcing abstinence, that is the number that matters most.
It Starts With People Ready for Change
Since we started tracking platform-wide data, CMI’s contingency management solution has supported more than 15,000 beneficiaries and patients. Every one of those numbers represents someone who showed up, engaged with treatment, and gave contingency management a chance to work for them.
Every Step Forward, Tracked
Behind that number is a much larger one: over 310,000 UTOX results have been captured on our platform. Each result is a data point in someone’s recovery — and, just as importantly, a moment where the system had to work correctly, consistently, and fast enough to matter. Contingency management only works when reinforcement follows behavior closely in time, so this is the operational backbone the rest of the model depends on.
And Recognized, Every Time
Verified progress doesn’t mean much if it isn’t recognized. Our platform has processed more than 300,000 awards — the moments where a negative test, a completed step, or another verified milestone was met with the kind of immediate, tangible reinforcement that contingency management research has consistently shown to work.
Real Rewards for Real Effort
Those awards add up to more than $4.6 million in incentives earned by the people using our platform. That figure is easy to read as a cost line, but it’s more accurately a measure of how much verified healthy behavior has actually happened — one small, immediate reward at a time.
Powered by Dedicated Care Teams
None of this runs on its own. More than 1,100 clinicians and administrators use CMI’s platform to manage caseloads, verify results, and deliver incentives — the people who make sure the model is implemented the way the evidence says it should be.
Across a Growing Network of Care
Those care teams now span more than 140 clinics using CMI’s solutions, a footprint that has grown steadily as more programs look for a structured, evidence-based way to bring contingency management into everyday clinical practice.
Why This Matters
None of these numbers is abstractions. They represent 15,000-plus people, more than 300,000 moments of recognized progress, and a growing network of clinics choosing an approach that fills a real gap — there still isn’t an FDA-approved medication for stimulant use disorder, which makes an evidence-based behavioral approach like contingency management especially important. Data like this is also a useful reminder for anyone in the field: the case for contingency management isn’t just the underlying research anymore. It’s also what happens when that research gets put into practice at scale.
If you’re newer to contingency management or want a clear, practical grounding in how the model works and why it’s effective, our guide “Understanding Contingency Management” walks through the fundamentals in plain language.
You may also be interested in our related post, “Benefits of CM”, which looks at why contingency management works in the first place.
For more insights like this one, visit the CMI blog:
For additional information contact:
Larry Klimczyk
Chief Commercial Officer
www.contingency-management.com
Book an appointment to learn more about Contingency Management, click here.
